Galena Biopharma Announces Proposed Public Offering of Common Stock an... 07 Feb 2017 - Globe Newswire Galena Biopharma Announces the Resignation of its President and Chief ... 31 Jan 2017 - Globe Newswire
Galena Biopharma
Maxim Group have a $4.00 target on the stock. The target would suggest a potential upside of 150.00 % from …
Galena Biopharma Inc (NASDAQ:GALE) shares are down big today after the company announced plans for a secondary stock offering. With Raymond James & Associates hired as the sole book-running manager for the …
Galena Biopharma, Inc’s (GALE - Free Report) shares plunged 82.8% after the company announced that it has discontinued the phase III PRESENT study on its lead candidate, NeuVax (nelipepimut-S). The decision …
ZACKS9mon
Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology ... to issue and sell shares of its common stock and warrants to purchase shares of its common stock. There can be no …
Galena Biopharma Inc (NASDAQ:GALE) has received an approval from its board of directors, to conduct a 1-for-20 reverse stock split. The company announced that it had already received approval from its shareholders, at its …
With the closing of some organic operations, there just isn’t enough variety nearby to stock his store, Maxey said ... Point north of Brunswick and …
Uncle Don
It's never a good thing when a company must resort to creative methods like a reverse stock split to stay listed on an exchange. However, Galena really didn't have a better alternative. Galena's lead candidate is GALE-401, a …
The Motley Fool
Luna Emery is a financial writer. She graduated with a degree in Economics. She has contributed to major financial websites and print publications for over 8 years. She handles much of this site's news coverage for …